If you have even one of these signs while on a GLP-1, you likely have PASS
ULTHERA VS
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England
Creates Sense of Satiety : GLP-1 agonists affect the areas of the brain that contribute to satiety
10.1016/j.cell.2016.09.014 Summary Keywords glucagon-like peptide-1, glucagon-like peptide-1 receptor agonist, glucagon, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis Citation Seghieri M, Christensen AS, Andersen A, Solini A, Knop FK and Vilsbll T (2018) Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
Heres how it works in real life: You may want to lose weight, but your body doesntand it fights back by lowering your metabolism, thereby making weight loss even harder, he says